Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-13 Sale | 2022-05-17 5:12 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 131,650 | $10.45 | $1,375,564 | 2,155,930 (Direct) | View |
| 2022-05-10 Sale | 2022-05-12 8:47 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 160,901 | $10.39 | $1,671,824 | 2,287,580 (Direct) | View |
| 2022-05-05 Sale | 2022-05-09 6:58 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 86,677 | $10.37 | $898,921 | 2,448,481 (Direct) | View |
| 2022-05-02 Sale | 2022-05-04 7:30 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 270,675 | $10.38 | $2,809,332 | 2,535,158 (Direct) | View |
| 2022-04-27 Sale | 2022-04-29 5:50 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 190,026 | $10.38 | $1,972,579 | 2,805,833 (Direct) | View |
| 2022-04-22 Sale | 2022-04-26 6:40 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 129,781 | $10.39 | $1,347,796 | 2,995,859 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 8:54 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 547,734 | $10.41 | $5,700,491 | 3,125,640 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 6:21 pm | Checkmate Pharmaceuticals Inc. | CMPI | Novo Holdings A/S 10% Owner | 8,110 | $2.8443 | $23,067 | 2,161,990 (Direct) | View |
| 2021-06-18 Purchase | 2021-06-21 4:26 pm | Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer | 7,224 | $6.04 | $43,633 | 815,734 (Direct) | View |
| 2021-06-16 Purchase | 2021-06-17 4:33 pm | Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer | 3,578 | $6.18 | $22,112 | 808,510 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-31 Disposition | 2022-05-31 10:14 am | N/A 2031-08-09 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 70,030 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:12 am | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 36,778 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:11 am | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Isacoff Oren Director | 30,030 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:08 am | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Colabuono Peter Director | 30,030 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:06 am | N/A 2031-12-16 | Checkmate Pharmaceuticals Inc. | CMPI | Yan Joy Director | 20,061 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:05 am | N/A 2032-01-26 | Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer | 278,480 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:04 am | N/A 2031-03-03 | Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer | 429,814 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:02 am | N/A 2032-01-29 | Checkmate Pharmaceuticals Inc. | CMPI | Wigginton Jon Marc Director | 20,061 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:02 am | N/A 2031-10-27 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director | 279,437 | $0 | 0 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 09:59 am | N/A 2032-03-01 | Checkmate Pharmaceuticals Inc. | CMPI | BASH ALAN Chief Executive Officer | 575,000 | $0 | 0 (Direct) | View |
| 2021-03-04 Option Award | 2022-04-28 5:03 pm | N/A 2031-03-03 | Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer | 54,600 | $0 | 54,600 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 4:10 pm | N/A 2032-03-01 | Checkmate Pharmaceuticals Inc. | CMPI | BASH ALAN Chief Executive Officer | 575,000 | $0 | 575,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 4:25 pm | N/A 2032-01-29 | Checkmate Pharmaceuticals Inc. | CMPI | Wigginton Jon Marc Director | 20,061 | $0 | 20,061 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 4:05 pm | N/A 2032-01-26 | Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer | 101,180 | $0 | 101,180 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 4:05 pm | N/A 2032-01-26 | Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer | 101,180 | $0 | 101,180 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-17 8:22 pm | N/A 2031-12-16 | Checkmate Pharmaceuticals Inc. | CMPI | Yan Joy Director | 20,061 | $0 | 20,061 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 6:54 pm | N/A 2031-10-27 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan See Remarks | 246,671 | $0 | 246,671 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-10 4:05 pm | N/A 2031-08-09 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Labinger Barry President and CEO | 85,950 | $0 | 85,950 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:24 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:22 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:20 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Isacoff Oren Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:18 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Colabuono Peter Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:18 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 10,030 | $0 | 10,030 (Direct) | View |